These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 29626528)

  • 1. Growth-inhibition of S180 residual-tumor by combination of cyclophosphamide and chitosan oligosaccharides in vivo.
    Zhai X; Yuan S; Yang X; Zou P; Shao Y; Abd El-Aty AM; Hacımüftüoğlu A; Wang J
    Life Sci; 2018 Jun; 202():21-27. PubMed ID: 29626528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor Effects of Orally and Intraperitoneally Administered Chitosan Oligosaccharides (COSs) on S180-Bearing/Residual Mouse.
    Zou P; Yang X; Zhang Y; Du P; Yuan S; Yang D; Wang J
    J Food Sci; 2016 Dec; 81(12):H3035-H3042. PubMed ID: 27802366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective Effect of Chitosan Oligosaccharides Against Cyclophosphamide-Induced Immunosuppression and Irradiation Injury in Mice.
    Zhai X; Yang X; Zou P; Shao Y; Yuan S; Abd El-Aty AM; Wang J
    J Food Sci; 2018 Feb; 83(2):535-542. PubMed ID: 29350748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Influences of FVP1 on the curative and negative effects of CTX].
    Yuan Q; Chen ZY; Yan MX
    Zhongguo Zhong Yao Za Zhi; 2005 Jun; 30(12):933-5. PubMed ID: 16124615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined use of insoluble β-glucan from the cell wall of Candida albicans and cyclophosphamide: Validation in S180 tumor-bearing mice.
    Qi Y; Hu X; Cui J; Chen J; Wu Q; Sun X; Shi Y
    Biomed Pharmacother; 2018 Jan; 97():1366-1372. PubMed ID: 29156526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of triterpenoid fractions from the rhizomes of Astilbe chinensis on cyclophosphamide-induced toxicity in tumor-bearing mice.
    Sun HX; Peng XY
    J Ethnopharmacol; 2008 Sep; 119(2):312-7. PubMed ID: 18692125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of cyclophosphamide-induced bystander effect on T cells for a successful tumor eradication in response to adoptive immunotherapy in mice.
    Proietti E; Greco G; Garrone B; Baccarini S; Mauri C; Venditti M; Carlei D; Belardelli F
    J Clin Invest; 1998 Jan; 101(2):429-41. PubMed ID: 9435316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Synergism and attenuation effects of taurine on cyclophosphamide].
    Zhao N; Wang L; Mou HY; Liang M; Yue W
    Ai Zheng; 2009 Mar; 28(3):244-8. PubMed ID: 19619437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulation and antitumor activity of kappa-carrageenan oligosaccharides.
    Yuan H; Song J; Li X; Li N; Dai J
    Cancer Lett; 2006 Nov; 243(2):228-34. PubMed ID: 16410037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunostimulatory activities of a low molecular weight antitumoral polysaccharide isolated from Agaricus blazei Murill (LMPAB) in Sarcoma 180 ascitic tumor-bearing mice.
    Niu YC; Liu JC; Zhao XM; Su FQ; Cui HX
    Pharmazie; 2009 Jul; 64(7):472-6. PubMed ID: 19694186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation of selenium-enriched Bifidobacterium longum and its effect on tumor growth and immune function of tumor-bearing mice.
    Yin Y; Wang RR; Wang Y; Wang JJ; Xu GX
    Asian Pac J Cancer Prev; 2014; 15(8):3681-6. PubMed ID: 24870777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunity and reproduction protective effects of Chitosan Oligosaccharides in Cyclophosphamide/Busulfan-induced premature ovarian failure model mice.
    Li X; Ye H; Su T; Hu C; Huang Y; Fu X; Zhong Z; Du X; Zheng Y
    Front Immunol; 2023; 14():1185921. PubMed ID: 37228612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll like receptor 4 (TLR4) mediates the stimulating activities of chitosan oligosaccharide on macrophages.
    Zhang P; Liu W; Peng Y; Han B; Yang Y
    Int Immunopharmacol; 2014 Nov; 23(1):254-61. PubMed ID: 25237008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low dose radiation increased the therapeutic efficacy of cyclophosphamide on S(180) sarcoma bearing mice.
    Yu HS; Xue HW; Guo CB; Song AQ; Shen FZ; Liang J; Deng C
    J Radiat Res; 2007 Jul; 48(4):281-8. PubMed ID: 17548941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Synergy and attenuation of cyclophosphamidum (CTX) activities by abalone polysaccharide].
    Wang B; Xu D; Xu S; Ling Y; Shao Z
    Zhong Yao Cai; 1999 Apr; 22(4):198-200. PubMed ID: 12575106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-inflammatory effects of low-molecular weight chitosan oligosaccharides in IgE-antigen complex-stimulated RBL-2H3 cells and asthma model mice.
    Chung MJ; Park JK; Park YI
    Int Immunopharmacol; 2012 Feb; 12(2):453-9. PubMed ID: 22266066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study on the antitumor effects and synergism and attenuation effects of gecko alcohol extract].
    Wang XL; Hao HY; Wang JG; Li RF
    Zhong Yao Cai; 2010 Aug; 33(8):1213-6. PubMed ID: 21213530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclophosphamide induces type I interferon and augments the number of CD44(hi) T lymphocytes in mice: implications for strategies of chemoimmunotherapy of cancer.
    Schiavoni G; Mattei F; Di Pucchio T; Santini SM; Bracci L; Belardelli F; Proietti E
    Blood; 2000 Mar; 95(6):2024-30. PubMed ID: 10706870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic anti-tumor activity of a novel immunomodulator, BCH-1393, in combination with cyclophosphamide.
    Kadhim S; Penney C; Lagraoui M; Heibein J; Attardo G; Zacharie B; Connolly T; Gagnon L
    Int J Immunopharmacol; 2000 Sep; 22(9):659-71. PubMed ID: 10884587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low Dose Cyclophosphamide Modulates Tumor Microenvironment by TGF-β Signaling Pathway.
    Zhong H; Lai Y; Zhang R; Daoud A; Feng Q; Zhou J; Shang J
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32023984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.